Campbell & Co Investment Adviser’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.81M Buy
35,361
+30,634
+648% +$8.47M 0.41% 24
2026
Q1
$1.4M Buy
+4,727
New +$1.4M 0.08% 385
2025
Q4
Sell
-2,948
Closed -$797K 1161
2025
Q3
$797K Buy
+2,948
New +$802K 0.06% 515
2024
Q4
Sell
-1,248
Closed -$275K 1096
2024
Q3
$275K Sell
1,248
-31,325
-96% -$6.48M 0.02% 932
2024
Q2
$6.4M Buy
+32,573
New +$6.73M 0.54% 10
2023
Q1
Sell
-2,686
Closed -$452K 837
2022
Q4
$452K Buy
+2,686
New +$467K 0.11% 357
2022
Q2
Sell
-3,014
Closed -$717K 704
2022
Q1
$717K Buy
+3,014
New +$708K 0.19% 154
2021
Q4
Sell
-3,600
Closed -$696K 638
2021
Q3
$696K Buy
+3,600
New +$729K 0.23% 130
2015
Q4
Sell
-2,738
Closed -$254K 101
2015
Q3
$254K Buy
+2,738
New +$260K 0.17% 218

Other funds holding CME

Campbell & Co Investment Adviser's CME Position: Q2 2026 in Review

Campbell & Co Investment Adviser increased its CME Group (CME) stake by 648% in Q2 2026, buying an estimated $8.47M and bringing the position to 35,361 shares worth $7.81M. The position accounts for 0.41% of the portfolio, ranked #24.

Campbell & Co Investment Adviser first reported a position in CME in Q3 2015 and has held it in 9 quarters since. 1,707 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Campbell & Co Investment Adviser held 35,361 shares of CME Group worth $7.81M as of Q2 2026.
  • Campbell & Co Investment Adviser bought 30,634 CME Group shares in Q2 2026, an estimated $8.47M.
  • CME Group made up 0.41% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #24 holding.
  • Campbell & Co Investment Adviser first reported a position in CME Group in Q3 2015 and has held it in 9 quarters since.
  • 1,707 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.